Comparing the efficacy of Trans-diagnostic Cognitive Behavior therapy versus pharmacological therapy on reducing symptoms severity of OCD with co-occurring anxiety and mood disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015072523333N1

Enrollment

Registered

2016-02-02

Start date

2015-04-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive Compulsive Disorder. , Depressive episode unspecified ,Anxiety disorder unspecified, ,Obsessive-compulsive disorder, Social phobias, Generalized anxiety disorder, Recurrent depressive disorder

Interventions

Intervention 1: Intervention group 1:Intervention in transdiagnostic cognitive behavior therapy (TCBT group) included 20 one hour sessions of psychotherapy that designed based on Balow's Unified Proto

Behavior

Treatment - Drugs

Intervention group 1:Intervention in transdiagnostic cognitive behavior therapy (TCBT group) included 20 one hour sessions of psychotherapy that designed based on Balow's Unified Protocol (2011).

Intervention 2: Pharmacotherapt intervention included 0.5 mg Haloperidol a time per day, and 50 mg serteraline a time per day to 100 mg two time per day after four weeks that prescribed by professiona

Control Group: Participants from control group didn't receive any intervetion and they were in wait list.

Eligibility

Sex/Gender

All

Age

76 Years to 49 Years

Inclusion criteria

Inclusion criteria: inclusion criteria is included: 1. age between 18-45 years 2. presence of one of the anxiety and unipolar mood disorders 3. eduction at least in 10 years 4. commitement to therapeutic sessions. exclusion criteria: 1. Absence of two or more session 2. presnce of other diagnoses such as SUD, cognitive disorders, and somatoform disorders. 3. not participating on one of the four assessments

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Disorder severity, OC amount, OC dimesion, work and social function. Timepoint: before the intervention, mid test, posttest, a month follow up. Method of measurement: clinical severity rating, obsessive compulsive inventory, dimensional obsessive compulsive scale, work and social adjustment scale.	—

Secondary

Measure	Time frame
Anxiety sensetivity. Timepoint: after ending the intervention. Method of measurement: anxiety sensetivity scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Farhad Taremian

Zanjan University of Medical Sciences

taremian@yahoo.com+98 24 3353 4500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026